Search results for "Complications."

showing 10 items of 1514 documents

The abdominal wall hernia in cirrhotic patients: A historical challenge

2018

Abstract Background The incidence rate of abdominal wall hernia is 20–40% in cirrhotic patients. A surgical approach was originally performed only if complication signs and symptoms occurred. Several recent studies have demonstrated the usefulness of elective surgery. During recent decades, the indications for surgical timing have changed. Methods Cirrhotic patients with abdominal hernia who underwent surgical operation for abdominal wall hernia repair at the Policlinico “Paolo Giaccone” at Palermo University Hospital between January 2010 and September 2016 were identified in a prospective database, and the data collected were retrospectively reviewed; patients’ medical and surgical records…

Liver CirrhosisMaleHerniaAbdominal wall hernia; Cirrhosis; Emergency; Risk factors; Surgery; Surgery; Emergency Medicinemedicine.medical_treatmentAbdominal Hernia030230 surgerylaw.inventionAbdominal wallPostoperative Complications0302 clinical medicinelawAscitesMedicineProspective StudiesAged 80 and overlcsh:Medical emergencies. Critical care. Intensive care. First aidMiddle AgedHernia repairIntensive care unitTreatment Outcomemedicine.anatomical_structureCirrhosisElective Surgical ProceduresEmergency MedicineFemale030211 gastroenterology & hepatologymedicine.symptomResearch Articlemedicine.medical_specialtylcsh:SurgeryRisk Assessment03 medical and health sciencesHumansHerniaElective surgeryHerniorrhaphyAgedRetrospective StudiesCirrhosibusiness.industryAbdominal Walllcsh:RD1-811lcsh:RC86-88.9medicine.diseaseSurgeryRisk factorsEmergencyAbdominal wall herniaSurgeryRisk factorbusinessComplication
researchProduct

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis

2008

BACKGROUND: While the likelihood of developing hepatocellular carcinoma (HCC) in patients coinfected with both HBV and HCV is increased, the role of previous exposure to HBV as a risk factor associated with tumor occurrence in subjects with HCV-related cirrhosis has not been fully investigated. AIM: To assess whether serum anti-HBc positivity, as a marker of previous HBV exposure, is associated with HCC development in HCV-related positive, hepatitis B surface antigen (HBsAg) negative patients with cirrhosis treated with alfa-interferon (IFN) monotherapy. PATIENTS AND: A database including 883 consecutive patients (557 men, mean age 54.7 yr) with histologically METHODS: proven cirrhosis trea…

Liver CirrhosisMalePathologyCirrhosisAdult Antibodies; Viral; blood Carcinoma; Hepatocellular; blood/pathology/virology Cohort Studies Female Hepatitis B Core Antigens; immunology Hepatitis B virus; immunology Hepatitis C; blood/complications/pathology Humans Liver Cirrhosis; blood/etiology/pathology Liver Neoplasms; blood/pathology/virology Male Middle Aged Retrospective Studies Risk FactorsAntibodies ViralGastroenterologyanti HBcCohort StudiesimmunologyRisk FactorsHBVViralHCCCIRRHOSISLiver NeoplasmsGastroenterologyvirus diseasesHBV HCV COINFECTIONMiddle AgedHepatitis B Core AntigensHepatitis CAdult; Antibodies Viral; Carcinoma Hepatocellular; Cohort Studies; Female; Hepatitis B Core Antigens; Hepatitis B virus; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Factors; GastroenterologyHepatocellular carcinomaHCVFemaleAdultmedicine.medical_specialtyHepatitis B virusCarcinoma Hepatocellularblood/pathology/virologyAntibodiesbloodblood/complications/pathologyInternal medicinemedicineHumansIn patientHEPATOCELLULAR CARCINOMAHEPATOCELLULAR CARCINOMA; HCV; HBV; CIRRHOSIS; HBV HCV COINFECTIONRetrospective StudiesHepatologybusiness.industryCarcinomaCancerHepatocellularmedicine.diseasedigestive system diseasesblood/etiology/pathologybusiness
researchProduct

Congenital Hepatic Fibrosis

2005

The disease presentation of autosomal recessive polycystic kidney disease (OMIM #263200, ARPKD) is highly variable and includes polycystic kidneys, pulmonary hypoplasia, and congenital hepatic fibrosis. The authors report an unusual case of ARPKD presenting with hepatosplenomegaly and cytopenia mimicking acute leukemia.

Liver CirrhosisMalePathologymedicine.medical_specialtyAdolescentPancytopeniaHepatosplenomegalyurologic and male genital diseasesPulmonary hypoplasiahemic and lymphatic diseasesmedicineHumanscytopeniaPolycystic Kidney Autosomal RecessivesplenomegalyCytopeniaAcute leukemiapolycystic kidney diseasebusiness.industryHematologymedicine.diseasePancytopeniaeye diseasesfemale genital diseases and pregnancy complicationsAutosomal Recessive Polycystic Kidney DiseaseOncologyDisease PresentationPediatrics Perinatology and Child HealthCongenital hepatic fibrosismedicine.symptomTomography X-Ray ComputedbusinessHepatomegalyJournal of Pediatric Hematology/Oncology
researchProduct

Efficacy of an escalating dose regimen of pegylated interferon ?-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation

2007

We evaluated the safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2a (PEG-IFN(alpha-2a)) and ribavirin in the early phase of recurrent hepatitis C after orthotopic liver transplantation (OLT). In this prospective study, 26 patients transplanted for hepatitis C virus cirrhosis with recurrent hepatitis C were treated 3.4 +/- 3.6 months after OLT and compared with an untreated historical control. PEG-IFN(alpha-2a) was initiated as monotherapy, following stepwise dose escalation up to 180 mug/week and the addition of ribavirin up to 1200 mg/day or maximally tolerated doses for 48 weeks. In the intent-to-treat analysis, 38% showed an early virological response (EVR…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosisHepatitis C virusmedicine.medical_treatmentHepacivirusLiver transplantationInterferon alpha-2medicine.disease_causeGastroenterologyAntiviral AgentsPolyethylene GlycolsCohort Studieschemistry.chemical_compoundPostoperative ComplicationsPegylated interferonRecurrenceInternal medicineRibavirinmedicineHumansAdverse effectAgedTransplantationbusiness.industryRibavirinInterferon-alphaAlanine TransaminaseHepatitis CMiddle Agedmedicine.diseaseHepatitis CRecombinant ProteinsLiver TransplantationRegimenTreatment OutcomechemistryImmunologyRNA ViralFemalebusinessmedicine.drugTransplant International
researchProduct

The abdominal wall incisional hernia repair in cirrhotic patients

2018

BACKGROUND: The incidence of abdominal wall hernia in cirrhotic patients with ascites is between 20 and 40%. Controversies regarding the treatment modality and surgical timing of abdominal wall incisional hernia repair in cirrhotic patients remain. The study proposed wants to analyze the abdominal incisional hernia repair in cirrhotic patients with ascites performed in a single center to determine post-operative morbidity, mortality and complication rate. PATIENTS AND METHODS: Cirrhotic patients with abdominal incisional hernia that underwent surgical operation for abdominal wall hernia repair at the "Policlinico Paolo Giaccone" at Palermo University Hospital between January 2015 and Decemb…

Liver CirrhosisMalemedicine.medical_specialtyIncisional herniamedicine.medical_treatment030230 surgeryAbdominal wall03 medical and health sciencesPostoperative Complications0302 clinical medicineRecurrenceSepsismedicineHumansIncisional HerniaHerniaElective surgeryHerniorrhaphyAgedRetrospective StudiesAged 80 and overabdominal wall hernia cirrhosisbusiness.industryMortality rateAbdominal WallAscitesRetrospective cohort studyLength of StayMiddle AgedHernia repairmedicine.diseaseHernia VentralSurgerysurgical procedures operativemedicine.anatomical_structureElective Surgical ProceduresSeromaFemaleOriginal Article030211 gastroenterology & hepatologyEmergenciesbusinessFollow-Up Studies
researchProduct

Color Doppler Ultrasound in Portal Hypertension

2020

Portal hypertension is one of the most important causes of morbidity and mortality in cirrhotic patients. A color Doppler evaluation of the left gastric vein (LGV) has proven utility in the prediction of esophageal varices and variceal bleeding in patients with portal hypertension. The purpose of this review is to discuss the ultrasound evaluation, imaging findings, and clinical application of Doppler ultrasound in the assessment of the LGV. Knowledge of the color Doppler technique and imaging findings of the LGV may help clinicians improve the monitoring of portal hypertension and predict patients with a high risk of esophageal varices.

Liver Cirrhosisesophageal varicemedicine.medical_specialtyleft gastric veinLeft gastric veinHemodynamicsEsophageal and Gastric Varicesurologic and male genital diseasesChronic liver disease030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineEsophageal varicesHypertension PortalHumansMedicineRadiology Nuclear Medicine and imagingUltrasonography Doppler Color030219 obstetrics & reproductive medicineRadiological and Ultrasound TechnologyPortal Veinultrasoundbusiness.industryUltrasoundHemodynamicschronic liver diseaseportal hypertensionColor doppler ultrasoundColor dopplermedicine.diseasefemale genital diseases and pregnancy complicationsPortal hypertensionRadiologycolor DopplerGastrointestinal HemorrhagebusinessJournal of Ultrasound in Medicine
researchProduct

Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference

2014

SummaryThe burden of infectious diseases both before and after liver transplantation is clearly attributable to the dysfunction of defensive mechanisms of the host, both as a result of cirrhosis, as well as the use of immunosuppressive agents.The present document represents the recommendations of an expert panel commended by the Italian Association for the Study of the Liver (AISF), on the prevention and management of infectious complications excluding hepatitis B, D, C, and HIV in the setting of liver transplantation.Due to a decreased response to vaccinations in cirrhosis as well as within the first six months after transplantation, the best timing for immunization is likely before transp…

Liver Cirrhosismedicine.medical_specialtyCirrhosismedicine.medical_treatmentLiver transplantationInfectionsInvasive fungal infectionPostoperative ComplicationsBacterial infectionsInvasive fungal infectionsTransplantation ImmunologyLower respiratory tract infectionHumansMedicineSmallpoxVoluntary Health AgenciesIntensive care medicineImmunosuppression TherapyViral infectionsInfection ControlCirrhosiLiver transplantationAttenuated vaccineHepatologybusiness.industryVaccinationHepatitis Bmedicine.diseaseVaccinationTransplantationBacterial infections; Cirrhosis; Invasive fungal infections; Liver transplantation; Viral infections; Humans; Immunosuppression; Infection; Infection Control; Italy; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Transplantation Immunology; Vaccination; Voluntary Health Agencies; HepatologyCirrhosisItalyViral infectionBacterial infections; Cirrhosis; Invasive fungal infections; Liver transplantation; Viral infectionsAISFImmunologyBacterial infectionInfectionbusinessImmunosuppression
researchProduct

Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded Trial

2010

Background. The aim of this prospective, randomized, double-blinded, placebo-controlled single center study was to evaluate an early steroid-free immunosuppression in liver transplant patients. Methods. From March 2000 to October 2004, 110 patients were included. All patients received tacrolimus and steroids during the first 2 weeks after orthotopic liver transplantation (OLT). Thereafter, patients in the steroid group (n=54) received steroids and the remaining 56 a placebo. After 6 months, the immunosuppression for all was steroid free. Thirty patients were hepatitis C positive. Five years after inclusion, patient survival, organ survival, steroid side effects, and recirrhosis in hepatitis…

Liver Cirrhosismedicine.medical_specialtyTime Factorsmedicine.medical_treatmentHypercholesterolemiaLiver transplantationSingle CenterPlaceboGastroenterologyTacrolimusPostoperative ComplicationsDouble-Blind MethodAdrenal Cortex HormonesRecurrenceInternal medicineDiabetes MellitusmedicineHumansSurvival rateAntibacterial agentTransplantationDose-Response Relationship Drugbusiness.industryGraft SurvivalImmunosuppressionHepatitis Cmedicine.diseaseHepatitis CTacrolimusLiver TransplantationSurgerySurvival RateTreatment OutcomebusinessImmunosuppressive AgentsTransplantation
researchProduct

Risk factors for bile leakage after liver resection for neoplastic disease.

2022

Biliary leakage (BL) remains the most frequent and feared complication after hepatoresective surgery. Placement of the abdominal drainage at the end of liver surgery remains controversial due to the delicate balance between risks and potential benefits in case of BL. The study was aimed to detect possible risk factors for BL occurrence after liver surgery. We enrolled all oncologic patients who underwent liver resection from June 2016 to March 2021. BL was diagnosed according to the ISGLS definition. We have examined demographic characteristics of the patients, type of neoplasia, presence of cirrhosis, neoadjuvant chemotherapy and type of intervention. Uni- and multivariable analyses were p…

Liver resectionBiliary Tract DiseasesLiver NeoplasmsAnastomotic LeakPost-hepatectomy complicationsPostoperative ComplicationsBile leakageRisk FactorsBileDrainageHepatectomyHumansSurgeryPostoperative drainageRetrospective StudiesUpdates in surgery
researchProduct

Anterior/Apical single incision mesh (Elevate™): Surgical experience, anatomical and functional results, and long-term complications

2021

Abstract Objective Pelvic organ prolapse is a common condition among post-menopausal women, and surgery is often the standard treatment proposed. Native tissue vaginal surgery is burdened by a high rate of recurrence, and mesh vaginal surgery has become current practice. The purpose of this study was to evaluate the safety and the effectiveness of the vaginal kit Anterior/Apical single incision mesh Elevate™ for the correction of anterior and apical compartment prolapse. Study design Data of patients with symptomatic anterior vaginal prolapse stage ≥ II, receiving mesh repair with the Anterior/Apical Elevate single incision system between January 2010 and January 2015 were retrieved. Prolap…

Long term complicationsmedicine.medical_specialtyUrinary Incontinence StressMesh vaginal surgeryUrinary incontinenceUrinary incontinenceUrogynecologyPelvic Organ ProlapseUrogynecology03 medical and health sciences0302 clinical medicineGynecologic Surgical ProceduresMedicineHumans030212 general & internal medicinePelvic organ030219 obstetrics & reproductive medicineUrinary bladderbusiness.industryUrinary retentionStandard treatmentObstetrics and GynecologySurgical MeshSurgerymedicine.anatomical_structureTreatment OutcomeUtero-vaginal prolapseReproductive MedicineSingle incisionVaginaFemalemedicine.symptombusinessFollow-Up Studies
researchProduct